Cleveland Clinic 12th Annual Basic and Clinical Immunology for the Busy Clinician 2024

Annual Basic and Clinical Immunology

Join us for the 12th Annual Basic & Clinical Immunology for the Busy Clinician

Annual Basic and Clinical Immunology

This 12th annual meeting will again attempt to provide a framework for busy clinicians who are interested in advances in basic and clinical immunology.  The meeting is divided into 3 sessions over 1-1/2 days.
In session 1 the meeting commences with a 30,000-foot review of the integrated immune response for those in need of a remedial review while other topics are chosen for the timeliness relevance and importance to the care of patients with immune mediated inflammatory diseases.

In session 2 a variety of clinical topics oriented around discrete IMIDS, with an emphasis on exploration of advances in immune-based therapeutics and/or immuno pathogenesis.  The final half day is dedicated to scientific advances in holistic and integrative care of IMIDS this year focusing on the challenges of chronic pain and fatigue and clinical practice.

Why Attend This Symposium?

• Network in-person in Scottsdale, AZ, or participate at your convenience from any location with live stream
• Learn from renowned experts in the field of immunology
• Review hot topics in immunology and old diseases, new treatments
• Interactive, roundtable discussions will address your questions
• New for 2024!  WELCOME RECEPTION – This reception offers an exceptional opportunity to reconnect with old friends, forge new connections, and engage in enlightening discussions about the day’s insightful sessions. In the spirit of scientific camaraderie, we invite you to share your thoughts, test your ideas, and uncover fresh insights amidst the bootcamp attendees. Don’t miss this chance to ignite your scientific passion and make lasting memories.

After completing this activity, participants will be able to:

• Describe the integrated immune response as it applies to host defense and immune-mediated diseases and recognize recent advances that may influence patient care
• Describe and critically appraise the immunologic mechanisms of action for targeted therapies and targeted synthetic therapies, FcRN inhibitors, CAR T cells and beyond as they apply to efficacy and safety across the spectrum of immune-mediated inflammatory diseases including PsA, SpA, RA, SLE vasculitis, and others
• Describe recent advances in the treatment of gout with biologic therapies and the role of complement in systemic vasculitis
• Critically appraise data on the role of integrative medicine on pain and fatigue in patients with rheumatic and immunologic diseases

Who Should Attend?

Clinicians caring for immune-mediated inflammatory diseases including rheumatology, allergy, immunology, gastroenterology, dermatology, pulmonology, and others.  In addition, clinicians of all specialties with interests in the intersection of Integrative Medicine and Immune-Mediated Diseases.